Johannes Plank

3.2k total citations
79 papers, 2.2k citations indexed

About

Johannes Plank is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Johannes Plank has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 14 papers in Genetics. Recurrent topics in Johannes Plank's work include Diabetes Management and Research (48 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (41 papers) and Diabetes Treatment and Management (17 papers). Johannes Plank is often cited by papers focused on Diabetes Management and Research (48 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (41 papers) and Diabetes Treatment and Management (17 papers). Johannes Plank collaborates with scholars based in Austria, United Kingdom and Germany. Johannes Plank's co-authors include Thomas R. Pieber, Andrea Siebenhofer, Karl Horvath, Andrea Berghold, Klaus Jeitler, Martin Ellmerer, Roman Hovorka, Malgorzata E. Wilinska, Ludovic J. Chassin and Manfred Bodenlenz and has published in prestigious journals such as Diabetes Care, Diabetes and Gut.

In The Last Decade

Johannes Plank

73 papers receiving 2.1k citations

Peers

Countries citing papers authored by Johannes Plank

Since Specialization

Citations

This map shows the geographic impact of Johannes Plank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Plank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Plank more than expected).

Fields of papers citing papers by Johannes Plank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Plank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Plank. The network helps show where Johannes Plank may publish in the future.

Co-authorship network of co-authors of Johannes Plank

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Plank. A scholar is included among the top collaborators of Johannes Plank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Plank. Johannes Plank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modelling Osteoporosis in Pre-Clinical Research—Challenges, Trends and New Approaches 2025 ·Cells ·Johannes Plank, Alexandra Damerau, Manuel Chacón, Paula Hoff, Frank Buttgereit, Moritz Pfeiffenberger	0
2	A Modular Perfusion Bioreactor Platform for Simulating Bone Regeneration and Fracture Healing: Integrating Mechanical Loading and Dual Perfusion for Advanced In Vitro Models 2025 ·Advanced Healthcare Materials ·Moritz Pfeiffenberger, Alexandra Damerau, Johannes Plank, (unknown), (unknown), Jan Saam, Paula Hoff, Timo Gaber, Frank Buttgereit	0
3	An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 study 2025 ·Clinical Nutrition ·(unknown), Angela Horvath, Nicole Feldbacher, (unknown), (unknown), Tobias Madl, Hansjörg Habisch, (unknown), (unknown), Johannes Plank, Florian Rainer, (unknown), Rudolf Stauber, (unknown), Martin Wagner, Gernot Zollner, Vanessa Stadlbauer	0
4	Evaluation of an implemented new insulin chart to improve quality and safety of diabetes care in a large university hospital: a follow-up study 2021 ·BMJ Open ·(unknown), Gerald Sendlhofer, (unknown), Barbara Semlitsch, Regina Riedl, Thomas R. Pieber, (unknown), Gernot Brunner, Johannes Plank	1
5	Case of nasogastric tube dysfunction 2018 ·Gut ·Florian Rainer, (unknown), Lukas Binder, Peter Fickert, Johannes Plank	3
6	Combined metformin-associated lactic acidosis and euglycemic ketoacidosis 2017 ·Wiener klinische Wochenschrift ·Verena Theiler‐Schwetz, Florian Eisner, Gernot Schilcher, Kathrin Eller, Johannes Plank, (unknown), Thomas R. Pieber, Julia K. Mader, Philipp Eller	16
7	Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type 2 diabetes. A post-hoc analysis of a before and after study 2016 ·International Journal of Medical Informatics ·(unknown), Peter Beck, (unknown), Julia K. Mader, Lukas Schaupp, Johannes Plank, (unknown), Christian Baumgärtner, Thomas R. Pieber	28
8	Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards 2015 ·Diabetes Technology & Therapeutics ·(unknown), Julia K. Mader, (unknown), Felix Aberer, (unknown), Thomas Augustin, Lukas Schaupp, (unknown), Peter Beck, Friedrich Fruhwald, Christian Schnedl, Alexander R. Rosenkranz, David B. Lumenta, Lars‐Peter Kamolz, Johannes Plank, Thomas R. Pieber	38
9	Efficacy and Safety of Glucose Control with Space GlucoseControl in the Medical Intensive Care Unit—An Open Clinical Investigation 2012 ·Diabetes Technology & Therapeutics ·Karin Amrein, Martin Ellmerer, Roman Hovorka, (unknown), (unknown), Dirk von Lewinski, Karl‐Heinz Smolle, Thomas R. Pieber, Johannes Plank	26
10	Evaluating Glycemic Control Algorithms by Computer Simulations 2011 ·Diabetes Technology & Therapeutics ·Malgorzata E. Wilinska, J Bláha, Ludovic J. Chassin, Jeremy Cordingley, Natalie Dormand, Martin Ellmerer, Martin Haluzı́k, Johannes Plank, Dirk Vlasselaers, Pieter Wouters, Roman Hovorka	23
11	Interleukin-6 produced in subcutaneous adipose tissue is linked to blood pressure control in septic patients 2010 ·Cytokine ·Dimas Ikeoka, Christoph Pachler, Stefan Korsatko, Julia K. Mader, (unknown), Manfred Bodenlenz, Johannes Plank, Karl‐Heinz Smolle, Martin Ellmerer, Thomas R. Pieber	9
12	Gesundheitsstatus der Typ-2-Diabetiker in Österreich aus der Sicht einer Qualitätssicherungs-Initiative 2009 ·Wiener Medizinische Wochenschrift ·Ivo Rakovac, Johannes Plank, Klaus Jeitler, Peter Beck, (unknown), Peter Mrak, Bernd Bauer, Thomas R. Pieber	8
13	Clinical Evaluation of Subcutaneous Lactate Measurement in Patients after Major Cardiac Surgery 2009 ·International Journal of Endocrinology ·Martin Ellmerer, Martin Haluzı́k, J Bláha, Jaromír Kremen, Š Svačina, (unknown), Dimas Ikeoka, Manfred Bodenlenz, Lukas Schaupp, Johannes Plank, Thomas R. Pieber	5
14	Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during ‘real‐life’ glucose excursions 2009 ·Diabetic Medicine ·Julia K. Mader, (unknown), Gerd Köhler, Johannes Plank, Gerlies Bock, Stefan Korsatko, Maria Ratzer, Dimas Ikeoka, H. Köhler, Thomas R. Pieber, Martin Ellmerer	7
15	Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients 2008 ·Intensive Care Medicine ·Christoph Pachler, Johannes Plank, (unknown), Ludovic J. Chassin, Malgorzata E. Wilinska, (unknown), Peter Kaufmann, Karl‐Heinz Smolle, Ernst Pilger, Thomas R. Pieber, Martin Ellmerer, Roman Hovorka	71
16	A simulation model of glucose regulation in the critically ill 2008 ·Physiological Measurement ·Roman Hovorka, Ludovic J. Chassin, Martin Ellmerer, Johannes Plank, Malgorzata E. Wilinska	80
17	Insulin glulisine, insulin lispro and regular human insulin show comparable end‐organ metabolic effects: an exploratory study 2007 ·Diabetes Obesity and Metabolism ·Karl Horvath, Gerlies Bock, Werner Regittnig, Manfred Bodenlenz, Andrea Wutte, Johannes Plank, Christoph Magnes, Frank Sinner, Sabine Fürst‐Recktenwald, (unknown), Thomas R. Pieber	10
18	Proportional Dose-Response Relationship and Lower Within-Patient Variability of Insulin Detemir and NPH Insulin in Subjects With Type 1 Diabetes Mellitus 2007 ·Experimental and Clinical Endocrinology & Diabetes ·Andrea Wutte, Johannes Plank, Manfred Bodenlenz, Christoph Magnes, Werner Regittnig, Frank Sinner, Birgitte Rønn, Milan Zdravković, Thomas R. Pieber	22
19	Plasma N‐terminal pro‐brain natriuretic peptide in Type 1 diabetic patients with and without diabetic nephropathy 2003 ·Diabetic Medicine ·Andrea Siebenhofer, Leong L. Ng, Johannes Plank, Andrea Berghold, Ronald Hödl, Thomas R. Pieber	21
20	[First two diagnosed cases of hemorrhagic nephroso-nephritis in Czechoslovakia; viral nephroso-nephritis of Far East]. 1955 ·PubMed ·Johannes Plank, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact